Hayashi, H., Matsubara, J., Nishihara, H., Baba, E., Kinoshita, I., Takami, H., Nishida, N., Tabata, M., Mukohara, T., Takahashi, M., Kenmotsu, H., Nishiwaki, S., Ando, Y., Sunami, K., Shimoi, T., Yamamoto, N. (2025). Phase II trial of trametinib in patients with advanced solid tumors harboring genomic alterations in the MAPK pathway: Results from the BELIEVE trial (NCCH1901).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3111